Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Chimeric antigen receptor T cells targeting CD79b show efficacy in lymphoma with or without co-targeting CD19.

Ormhøj M, Scarfò I, Cabral ML, Bailey SR, Lorrey SJ, Bouffard AA, Castano AP, Larson RC, Riley LS, Schmidts A, Choi BD, Andersen RS, Cédile O, Nyvold CG, Haaber J, Gjerstorff MF, Ditzel HJ, Weinstock DM, Barington T, Frigault MJ, Maus MV.

Clin Cancer Res. 2019 Aug 22. pii: clincanres.1337.2019. doi: 10.1158/1078-0432.CCR-19-1337. [Epub ahead of print]

PMID:
31439577
2.

Disengaging with the cancerous body.

Merrild CH, Andersen RS.

Health (London). 2019 May 10:1363459319848049. doi: 10.1177/1363459319848049. [Epub ahead of print]

PMID:
31072128
3.

Coordinating objects of care: Exploring the role of case managers as brokers in cancer patient pathways.

Aarhus R, Tjørnhøj-Thomsen T, Tarp B, Vedsted P, Andersen RS.

Eur J Cancer Care (Engl). 2019 May;28(3):e13017. doi: 10.1111/ecc.13017. Epub 2019 Feb 14.

PMID:
30767292
4.

Analysis of novel domain-specific mutations in the zebrafish ndr2/cyclops gene generated using CRISPR-Cas9 RNPs.

Turner AN, Andersen RS, Bookout IE, Brashear LN, Davis JC, Gahan DM, Davis JC, Gotham JP, Hijaz BA, Kaushik AS, Mcgill JB, Miller VL, Moseley ZP, Nowell CL, Patel RK, Rodgers MC, Patel RK, Shihab YA, Walker AP, Glover SR, Foster SD, Challa AK.

J Genet. 2018 Dec;97(5):1315-1325.

5.

The cancer may come back: experiencing and managing worries of relapse in a North Norwegian village after treatment.

Skowronski M, Risør MB, Andersen RS, Foss N.

Anthropol Med. 2018 Jun 18:1-15. doi: 10.1080/13648470.2017.1391172. [Epub ahead of print]

PMID:
29913070
6.

It is important that the process goes quickly, isn't it?" A qualitative multi-country study of colorectal or lung cancer patients' narratives of the timeliness of diagnosis and quality of care.

Malmström M, Rasmussen BH, Bernhardson BM, Hajdarevic S, Eriksson LE, Andersen RS, MacArtney JI.

Eur J Oncol Nurs. 2018 Jun;34:82-88. doi: 10.1016/j.ejon.2018.04.002.

PMID:
29784144
7.

Adoptive cancer immunotherapy using DNA-demethylated T helper cells as antigen-presenting cells.

Kirkin AF, Dzhandzhugazyan KN, Guldberg P, Fang JJ, Andersen RS, Dahl C, Mortensen J, Lundby T, Wagner A, Law I, Broholm H, Madsen L, Lundell-Ek C, Gjerstorff MF, Ditzel HJ, Jensen MR, Fischer W.

Nat Commun. 2018 Mar 6;9(1):785. doi: 10.1038/s41467-018-03217-9.

8.

Patients' initial steps to cancer diagnosis in Denmark, England and Sweden: what can a qualitative, cross-country comparison of narrative interviews tell us about potentially modifiable factors?

MacArtney J, Malmström M, Overgaard Nielsen T, Evans J, Bernhardson BM, Hajdarevic S, Chapple A, Eriksson LE, Locock L, Rasmussen B, Vedsted P, Tishelman C, Andersen RS, Ziebland S.

BMJ Open. 2017 Nov 19;7(11):e018210. doi: 10.1136/bmjopen-2017-018210.

9.

A novel approach for automatic detection of Atrial Fibrillation based on Inter Beat Intervals and Support Vector Machine.

Andersen RS, Poulsen ES, Puthusserypady S.

Conf Proc IEEE Eng Med Biol Soc. 2017 Jul;2017:2039-2042. doi: 10.1109/EMBC.2017.8037253.

PMID:
29060297
10.

Activation of professional and personal network relations when experiencing a symptom: a population-based cross-sectional study.

Elnegaard S, Andersen RS, Pedersen AF, Jarbøl DE.

BMJ Open. 2017 Oct 15;7(10):e017620. doi: 10.1136/bmjopen-2017-017620.

11.

Reconfiguring diagnostic work in Danish general practice; regulation, triage and the secretaries as diagnostician.

Andersen RS, Aarhus R.

Anthropol Med. 2017 Jul 31:1-15. doi: 10.1080/13648470.2017.1334040. [Epub ahead of print]

PMID:
28758798
12.

Class, Social Suffering, and Health Consumerism.

Merrild CH, Risør MB, Vedsted P, Andersen RS.

Med Anthropol. 2016 Nov-Dec;35(6):517-528. Epub 2015 Oct 12.

PMID:
26458052
13.

Neoantigen landscape dynamics during human melanoma-T cell interactions.

Verdegaal EM, de Miranda NF, Visser M, Harryvan T, van Buuren MM, Andersen RS, Hadrup SR, van der Minne CE, Schotte R, Spits H, Haanen JB, Kapiteijn EH, Schumacher TN, van der Burg SH.

Nature. 2016 Aug 4;536(7614):91-5. Epub 2016 Jun 27.

PMID:
27350335
14.

Resisting "Reason": A Comparative Anthropological Study of Social Differences and Resistance toward Health Promotion and Illness Prevention in Denmark.

Merrild CH, Andersen RS, Risør MB, Vedsted P.

Med Anthropol Q. 2017 Jun;31(2):218-236. doi: 10.1111/maq.12295. Epub 2016 Jun 30.

PMID:
27130785
15.

Situating Social Differences in Health and Illness Practices.

Merrild CH, Vedsted P, Andersen RS.

Perspect Biol Med. 2016;59(4):547-561. doi: 10.1353/pbm.2016.0047.

PMID:
28690244
16.

Self-reported symptoms and healthcare seeking in the general population--exploring "The Symptom Iceberg".

Elnegaard S, Andersen RS, Pedersen AF, Larsen PV, Søndergaard J, Rasmussen S, Balasubramaniam K, Svendsen RP, Vedsted P, Jarbøl DE.

BMC Public Health. 2015 Jul 21;15:685. doi: 10.1186/s12889-015-2034-5.

17.

Juggling efficiency. An ethnographic study exploring healthcare seeking practices and institutional logics in Danish primary care settings.

Andersen RS, Vedsted P.

Soc Sci Med. 2015 Mar;128:239-45. doi: 10.1016/j.socscimed.2015.01.037. Epub 2015 Jan 22.

PMID:
25625230
18.

Ectopic expression of cancer/testis antigen SSX2 induces DNA damage and promotes genomic instability.

Greve KB, Lindgreen JN, Terp MG, Pedersen CB, Schmidt S, Mollenhauer J, Kristensen SB, Andersen RS, Relster MM, Ditzel HJ, Gjerstorff MF.

Mol Oncol. 2015 Feb;9(2):437-49. doi: 10.1016/j.molonc.2014.09.001. Epub 2014 Oct 6.

19.

Global Health Care-seeking Discourses Facing Local Clinical Realities: Exploring the Case of Cancer.

Andersen RS, Tørring ML, Vedsted P.

Med Anthropol Q. 2015 Jun;29(2):237-55. doi: 10.1111/maq.12148. Epub 2014 Oct 30.

PMID:
25355457
20.

The Danish Symptom Cohort: Questionnaire and Feasibility in the Nationwide Study on Symptom Experience and Healthcare-Seeking among 100 000 Individuals.

Rasmussen S, Søndergaard J, Larsen PV, Balasubramaniam K, Elnegaard S, Svendsen RP, Andersen RS, Pedersen AF, Vedsted P, Jarbøl DE.

Int J Family Med. 2014;2014:187280. doi: 10.1155/2014/187280. Epub 2014 Jul 23.

21.

Towards a clinically useful diagnosis for mild-to-moderate conditions of medically unexplained symptoms in general practice: a mixed methods study.

Rask MT, Andersen RS, Bro F, Fink P, Rosendal M.

BMC Fam Pract. 2014 Jun 12;15:118. doi: 10.1186/1471-2296-15-118.

22.

The importance of contextualization. Anthropological reflections on descriptive analysis, its limitations and implications.

Andersen RS, Risør MB.

Anthropol Med. 2014 Dec;21(3):345-356. Epub 2014 Feb 3.

PMID:
24484056
23.

Multiple perspectives on symptom interpretation in primary care research.

Rosendal M, Jarbøl DE, Pedersen AF, Andersen RS.

BMC Fam Pract. 2013 Nov 4;14:167. doi: 10.1186/1471-2296-14-167.

24.

High frequency of T cells specific for cryptic epitopes in melanoma patients.

Andersen RS, Andersen SR, Hjortsø MD, Lyngaa R, Idorn M, Køllgård TM, Met O, Thor Straten P, Hadrup SR.

Oncoimmunology. 2013 Jul 1;2(7):e25374.

25.

[Visual analogue scale for measuring post-operative pain].

Rauh KH, Andersen RS, Rosenberg J.

Ugeskr Laeger. 2013 Jun 10;175(24):1712-6. Review. Danish.

PMID:
23763932
26.

Depletion of T lymphocytes is correlated with response to temozolomide in melanoma patients.

Iversen TZ, Brimnes MK, Nikolajsen K, Andersen RS, Hadrup SR, Andersen MH, Bastholt L, Svane IM.

Oncoimmunology. 2013 Feb 1;2(2):e23288.

27.

BRAF inhibition improves tumor recognition by the immune system: Potential implications for combinatorial therapies against melanoma involving adoptive T-cell transfer.

Donia M, Fagone P, Nicoletti F, Andersen RS, Høgdall E, Straten PT, Andersen MH, Svane IM.

Oncoimmunology. 2012 Dec 1;1(9):1476-1483.

28.

Adoptive cell therapy with autologous tumor infiltrating lymphocytes and low-dose Interleukin-2 in metastatic melanoma patients.

Ellebaek E, Iversen TZ, Junker N, Donia M, Engell-Noerregaard L, Met Ö, Hölmich LR, Andersen RS, Hadrup SR, Andersen MH, thor Straten P, Svane IM.

J Transl Med. 2012 Aug 21;10:169. doi: 10.1186/1479-5876-10-169.

29.

Parallel detection of antigen-specific T cell responses by combinatorial encoding of MHC multimers.

Andersen RS, Kvistborg P, Frøsig TM, Pedersen NW, Lyngaa R, Bakker AH, Shu CJ, Straten Pt, Schumacher TN, Hadrup SR.

Nat Protoc. 2012 Apr 12;7(5):891-902. doi: 10.1038/nprot.2012.037.

PMID:
22498709
30.

The Aarhus statement: improving design and reporting of studies on early cancer diagnosis.

Weller D, Vedsted P, Rubin G, Walter FM, Emery J, Scott S, Campbell C, Andersen RS, Hamilton W, Olesen F, Rose P, Nafees S, van Rijswijk E, Hiom S, Muth C, Beyer M, Neal RD.

Br J Cancer. 2012 Mar 27;106(7):1262-7. doi: 10.1038/bjc.2012.68. Epub 2012 Mar 13.

31.

Dissection of T-cell antigen specificity in human melanoma.

Andersen RS, Thrue CA, Junker N, Lyngaa R, Donia M, Ellebæk E, Svane IM, Schumacher TN, Thor Straten P, Hadrup SR.

Cancer Res. 2012 Apr 1;72(7):1642-50. doi: 10.1158/0008-5472.CAN-11-2614. Epub 2012 Feb 6.

32.

Does the organizational structure of health care systems influence care-seeking decisions? A qualitative analysis of Danish cancer patients' reflections on care-seeking.

Andersen RS, Vedsted P, Olesen F, Bro F, Søndergaard J.

Scand J Prim Health Care. 2011 Sep;29(3):144-9. doi: 10.3109/02813432.2011.585799. Epub 2011 Aug 23.

33.

[From symptoms to seeking doctor].

Pedersen AF, Andersen RS.

Ugeskr Laeger. 2011 Jun 13;173(24):1709-12. Danish.

PMID:
21696672
34.

Spontaneous cytotoxic T-Cell reactivity against indoleamine 2,3-dioxygenase-2.

Sørensen RB, Køllgaard T, Andersen RS, van den Berg JH, Svane IM, Straten Pt, Andersen MH.

Cancer Res. 2011 Mar 15;71(6):2038-44. doi: 10.1158/0008-5472.CAN-10-3403.

35.

Identification of a cyclin B1-derived CTL epitope eliciting spontaneous responses in both cancer patients and healthy donors.

Andersen RS, Sørensen RB, Ritter C, Svane IM, Becker JC, thor Straten P, Andersen MH.

Cancer Immunol Immunother. 2011 Feb;60(2):227-34. doi: 10.1007/s00262-010-0933-y. Epub 2010 Oct 28.

36.

'Containment' as an analytical framework for understanding patient delay: a qualitative study of cancer patients' symptom interpretation processes.

Andersen RS, Paarup B, Vedsted P, Bro F, Soendergaard J.

Soc Sci Med. 2010 Jul;71(2):378-385. doi: 10.1016/j.socscimed.2010.03.044. Epub 2010 Apr 27.

PMID:
20488607
37.

Patient delay in cancer studies: a discussion of methods and measures.

Andersen RS, Vedsted P, Olesen F, Bro F, Søndergaard J.

BMC Health Serv Res. 2009 Oct 19;9:189. doi: 10.1186/1472-6963-9-189.

38.

Qualitative description - the poor cousin of health research?

Neergaard MA, Olesen F, Andersen RS, Sondergaard J.

BMC Med Res Methodol. 2009 Jul 16;9:52. doi: 10.1186/1471-2288-9-52.

39.

Parallel detection of antigen-specific T-cell responses by multidimensional encoding of MHC multimers.

Hadrup SR, Bakker AH, Shu CJ, Andersen RS, van Veluw J, Hombrink P, Castermans E, Thor Straten P, Blank C, Haanen JB, Heemskerk MH, Schumacher TN.

Nat Methods. 2009 Jul;6(7):520-6. doi: 10.1038/nmeth.1345. Epub 2009 Jun 21.

PMID:
19543285
40.

The 1170 A-P single-nucleotide polymorphism (SNP) in the Her-2/neu protein (HER2) as a minor histocompatibility antigen (mHag).

Wenandy L, Kollgaard T, Letsch A, Andersen RS, Stather D, Seremet T, Svane IM, Vindeløv L, Andersen MH, thor Straten P.

Leukemia. 2009 Oct;23(10):1926-9. doi: 10.1038/leu.2009.112. Epub 2009 May 21. No abstract available.

PMID:
19458631
41.

CD8 T-cell responses against cyclin B1 in breast cancer patients with tumors overexpressing p53.

Sørensen RB, Andersen RS, Svane IM, Engell-Noerregaard L, Hadrup SR, Balslev E, Andersen MH, thor Straten P.

Clin Cancer Res. 2009 Mar 1;15(5):1543-9. doi: 10.1158/1078-0432.CCR-08-1412. Epub 2009 Feb 17.

42.

[General practitioners' experience from systematic review of patient cases as a learning vehicle in general practice].

Andersen RS, Søndergaard J, Hansen RP, Bro F.

Ugeskr Laeger. 2009 Jan 19;171(4):209-11. Danish.

PMID:
19174033
43.

A modified epitope identified for generation and monitoring of PSA-specific T cells in patients on early phases of PSA-based immunotherapeutic protocols.

Lundberg K, Roos AK, Pavlenko M, Leder C, Wehrum D, Guevara-Patiño J, Andersen RS, Pisa P.

Vaccine. 2009 Mar 4;27(10):1557-65. doi: 10.1016/j.vaccine.2009.01.011. Epub 2009 Jan 24.

PMID:
19171173
44.

Learning based on patient case reviews: an interview study.

Andersen RS, Hansen RP, Søndergaard J, Bro F.

BMC Med Educ. 2008 Sep 5;8:43. doi: 10.1186/1472-6920-8-43.

45.

Mcl-1 and anticancer vaccination: identification of an HLA-A2-restricted epitope.

Andersen RS, Wenandy L, Sørensen RB, thor Straten P, Andersen MH.

Leukemia. 2008 Mar;22(3):668-9. Epub 2007 Sep 6. No abstract available.

PMID:
17805325
46.

[Lithium induced dysfunction of the parathyroid hormone].

Valeur N, Andersen RS.

Ugeskr Laeger. 2002 Jan 28;164(5):639-40. Danish.

PMID:
11871216
47.

[Angiotensin II antagonists versus ACE inhibitors in the treatment of raised blood pressure].

Andersen RS, Christensen S.

Ugeskr Laeger. 2001 Dec 10;163(50):7036-9. Review. Danish.

PMID:
11794033
48.

[Hyperparathyroidism secondary to anticonvulsant treatment].

Andersen RS, Valeur N.

Ugeskr Laeger. 2001 Nov 5;163(45):6288-9. Danish.

PMID:
11723691
49.

Why adoptees search: motives and more.

Andersen RS.

Child Welfare. 1988 Jan-Feb;67(1):15-9.

PMID:
3338334
50.

Comparison between midazolam and thiopentone-based balanced anaesthesia for day-case surgery.

Crawford ME, Carl P, Andersen RS, Mikkelsen BO.

Br J Anaesth. 1984 Feb;56(2):165-9.

Supplemental Content

Loading ...
Support Center